PNC Financial Services Group
KRYS icon

PNC Financial Services Group’s Krystal Biotech KRYS Stock Holding History

PNC Financial Services Group’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$978K Buy
2,631
+646
+33% +$193K ﹤0.01% 1412
2026
Q1 		$513K Buy
1,985
+289
+17% +$76.9K ﹤0.01% 1666
2025
Q4 		$418K Buy
1,696
+2
+0.1% +$421 ﹤0.01% 1795
2025
Q3 		$299K Buy
1,694
+272
+19% +$40.7K ﹤0.01% 2017
2025
Q2 		$195K Sell
1,422
-719
-34% -$106K ﹤0.01% 2217
2025
Q1 		$386K Buy
2,141
+461
+27% +$77.5K ﹤0.01% 1710
2024
Q4 		$263K Buy
1,680
+36
+2% +$6.39K ﹤0.01% 2008
2024
Q3 		$299K Buy
1,644
+158
+11% +$30.5K ﹤0.01% 1905
2024
Q2 		$273K Buy
1,486
+565
+61% +$94.9K ﹤0.01% 1928
2024
Q1 		$164K Buy
921
+601
+188% +$83.5K ﹤0.01% 2316
2023
Q4 		$39.7K Sell
320
-100
-24% -$11.1K ﹤0.01% 3083
2023
Q3 		$48.7K Buy
420
+48
+13% +$5.86K ﹤0.01% 2973
2023
Q2 		$43.7K Buy
372
+124
+50% +$12.7K ﹤0.01% 3141
2023
Q1 		$19.9K Hold
248
– – ﹤0.01% 3498
2022
Q4 		$19.6K Buy
248
+70
+39% +$5.2K ﹤0.01% 3479
2022
Q3 		$12K Buy
+178
New +$12.9K ﹤0.01% 3670
2022
Q2 		– Sell
-28
Closed -$2K – 4617
2022
Q1 		$2K Buy
28
+26
+1,300% +$1.62K ﹤0.01% 4203
2021
Q4 		$0 Buy
+2
New +$116 ﹤0.01% 4534

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

PNC Financial Services Group's KRYS Position: Q2 2026 in Review

PNC Financial Services Group increased its Krystal Biotech (KRYS) stake by 33% in Q2 2026, buying an estimated $193K and bringing the position to 2,631 shares worth $978K. The position accounts for ﹤0.01% of the portfolio, ranked #1412.

PNC Financial Services Group first reported a position in KRYS in Q4 2021 and has held it in 18 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • PNC Financial Services Group held 2,631 shares of Krystal Biotech worth $978K as of Q2 2026.
  • PNC Financial Services Group bought 646 Krystal Biotech shares in Q2 2026, an estimated $193K.
  • Krystal Biotech made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #1412 holding.
  • PNC Financial Services Group first reported a position in Krystal Biotech in Q4 2021 and has held it in 18 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.